Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Free Cash Flow (2019 - 2025)

Historic Free Cash Flow for Revolution Medicines (RVMD) over the last 7 years, with Q3 2025 value amounting to -$210.7 million.

  • Revolution Medicines' Free Cash Flow fell 5728.06% to -$210.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$777.1 million, marking a year-over-year decrease of 4100.22%. This contributed to the annual value of -$567.7 million for FY2024, which is 5845.45% down from last year.
  • Revolution Medicines' Free Cash Flow amounted to -$210.7 million in Q3 2025, which was down 5728.06% from -$229.2 million recorded in Q2 2025.
  • Over the past 5 years, Revolution Medicines' Free Cash Flow peaked at -$35.4 million during Q2 2021, and registered a low of -$229.2 million during Q2 2025.
  • In the last 5 years, Revolution Medicines' Free Cash Flow had a median value of -$68.2 million in 2023 and averaged -$102.8 million.
  • In the last 5 years, Revolution Medicines' Free Cash Flow crashed by 1244.54% in 2023 and then crashed by 15522.92% in 2024.
  • Over the past 5 years, Revolution Medicines' Free Cash Flow (Quarter) stood at -$40.4 million in 2021, then tumbled by 59.87% to -$64.7 million in 2022, then tumbled by 90.03% to -$122.9 million in 2023, then decreased by 13.54% to -$139.5 million in 2024, then plummeted by 51.0% to -$210.7 million in 2025.
  • Its Free Cash Flow stands at -$210.7 million for Q3 2025, versus -$229.2 million for Q2 2025 and -$197.7 million for Q1 2025.